About us

Cosma SA, formerly known as Cosma Group S.A., is a growing company, in the pharmaceutical, food and cosmetics markets, with a history dating back to 2015.  

The company's origins were associated with the "Vabun" brand, which changed its name to Cosma Group. In 2022, the merger with Cosma Cannabis Sp. z o. o. began, formally completed in March 2023, resulting in the merger of Cosma Group S.A. with Cosma Cannabis Sp. z o.o. under the name Cosma S.A. (ticker: COS) - an entity listed on the New Connect market of the Warsaw Stock Exchange. The Board of Directors and Supervisory Board of Cosma S.A. are mostly founders of Cosma Cannabis, which has been active in the cannabis market since 2018. The company's headquarters are currently located in Warsaw at European Square 1, floor 40.

We are one of the first companies in the hemp dietary supplements and pharmaceutical raw materials industry in Poland. We have an integrated production, supply and distribution chain in this category. We are currently focusing on manufacturing and importing products containing phytocannabinoids and other phyto plant compounds targeted for use in the pharmaceutical, cosmetic, food and veterinary industries.
We have the facilities and competence to produce plant extracts ourselves, process them, and pack them into finished products.

Scope of activity

We are focusing our efforts on recipe development and portfolio development under three brands: Cosma, Full Spectrum and Green Paw. We currently sell them in more than 1,000 outlets covering pharmacy, FMCG and pet chains. We plan to continuously develop and establish cooperation with more entities in the pharmaceutical and drugstore markets.

A very important element of our activity is cooperation with the medical and pharmaceutical community, carried out through the organization of meetings with our representatives and education on the use of cannabinoids, i.e. THC, CBD, CBG, CBN etc. in medicinal therapies. To this end, we organize, among other things, periodic webinars and conference meetings, to which we invite all interested parties.

We have successfully carried out internal organizational and certification work related to obtaining the status of a responsible entity (MAH - Market Authorization Holder), which allows us to commercialize medicinal products containing cannabinoids. This involves the cyclical launch of new pharmaceutical raw materials and drugs (OTC, RX) planned for the next few years. Together with our partners as MAH, we are working on the development of new innovative products.

We also conduct internal and external research and development (R&D) work in the areas of manufacturing new products and active substances. The results of the work are commercialized in private label or white label brands. We offer cooperation in the distribution of private labels, development of new products for private label customers and contract manufacturing.

Development plans

In 2025, we plan to arrange the Group's corporate structure, along with carrying out planned acquisitions. We also intend to develop our responsible entity status (MAH - Market Authorization Holder), which allows us to commercialize medicinal products. This involves the planned launch of new pharmaceutical raw materials and drugs (OTC, RX). Together with our partners as MAH, we plan to introduce innovative products
and methods of administration of cannabinoids.

Cosma S.A. manufacturing plant.

The facility allows for extraction, distillation, blending, testing and performing everything needed to create safe and effective products.

We create products from formulation to production to packaging, so we have full control over the entire process. Comprehensive from A to Z.

We have created 4 proprietary brands that are successfully operating in the market.

The factory is capable of serving a large number of customers, so we invite you to cooperate on a private or white label basis.